Title : Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.

Pub. Date : 2018 Jan 5

PMID : 29133031






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model. Chloroquine TNF superfamily member 10 Rattus norvegicus
2 This study aimed to evaluate chloroquine"s (CQ) ability to trigger TRAIL/TRAILR2 apoptotic pathway in thioacetamide (TAA)-induced hepatocellular carcinoma (HCC) either alone or in combination with doxorubicin (DOX). Chloroquine TNF superfamily member 10 Rattus norvegicus
3 This study aimed to evaluate chloroquine"s (CQ) ability to trigger TRAIL/TRAILR2 apoptotic pathway in thioacetamide (TAA)-induced hepatocellular carcinoma (HCC) either alone or in combination with doxorubicin (DOX). Chloroquine TNF superfamily member 10 Rattus norvegicus
4 This study aimed to evaluate chloroquine"s (CQ) ability to trigger TRAIL/TRAILR2 apoptotic pathway in thioacetamide (TAA)-induced hepatocellular carcinoma (HCC) either alone or in combination with doxorubicin (DOX). Thioacetamide TNF superfamily member 10 Rattus norvegicus
5 CQ induced apoptosis via upregulation of TRAIL/TRAILR2, caspase-8, caspase-3 and caspase-8 genes and downregulation of BCL-2 gene. Chloroquine TNF superfamily member 10 Rattus norvegicus